Development and Validation of Bioanalytical Method for Determination of Nebivolol and Valsartan in Human Plasma by Using RP-HPLC

Kategoria artykułu: Original Paper

Data publikacji: 12 mar 2022

Zakres stron: 49 - 58

Otrzymano: 14 kwi 2018

Przyjęty: 01 cze 2018

DOI: https://doi.org/10.2478/afpuc-2021-0019

Słowa kluczowe

Nebivolol, Valsartan, Atorvastatin, RP-HPLC, Method development, ICH Guidelines (ICH M10), Validation

© 2021 R. N. Kachave et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.